Allergic contact dermatitis due to animal (cat) (dog) dander
Methodology & AI Transparency ⓘ
Allergic contact dermatitis due to animal (cat) (dog) dander Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: For patients presenting with Allergic contact dermatitis due to animal (cat) (dog) dander (ICD-10-CM L23.81), Dermatology: Acne, Eczema, Psoriasis & Rosacea protocols prioritize dermoscopy or punch in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: biopsy when atypical) paired with baseline and interval Affected Body Surface in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: Area (BSA /) assessment.
- 2 Real-world patient consensus: Mapped to Dermatology: Acne, Eczema, Psoriasis & Rosacea under ICD-10-CM L23.81 for Allergic contact dermatitis due to animal (cat) (dog) dander clinical workups.
- 3 Typical cash cost range: Clinicians assessing Allergic contact dermatitis due to animal (cat) (dog) dander focus on epidermal barrier filaggrin/ceramide in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: disruption) and targeted history.
- 4 Top reported side effects / signs: Objective lab/clinical target for Allergic contact dermatitis due to animal (cat) (dog) dander: Affected Body Surface in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: Area (BSA /) (Clear or Almost Clear (IGA 0–1) (L23.81)) and Fasting Lipids & in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: ALT (if systemic).
Ask our AI Specialists anything about Allergic contact dermatitis due to animal (cat) (dog) dander
What Is Allergic contact dermatitis due to animal (cat) (dog) dander?
For patients presenting with Allergic contact dermatitis due to animal (cat) (dog) dander (ICD-10-CM L23.81), Dermatology: Acne, Eczema, Psoriasis & Rosacea protocols prioritize dermoscopy or punch in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: biopsy when atypical) paired with baseline and interval Affected Body Surface in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: Area (BSA /) assessment.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Allergic contact dermatitis due to animal (cat) (dog) dander (ICD-10 L23.81) is driven by epidermal barrier filaggrin/ceramide in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: disruption); specialists in Dermatology: Acne, Eczema, Psoriasis & Rosacea monitor Fasting Lipids & in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: ALT (if systemic) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81): post-inflammatory hyperpigmentation, facial in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: flushing, or pitted)
- • Secondary Allergic contact dermatitis due to animal (cat) (dog) dander clinical sign: recurrent flares triggered in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: by UV exposure,)
- • Symptom flares in Allergic contact dermatitis due to animal (cat) (dog) dander correlating with Affected Body Surface in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: Area (BSA /) deviation outside Clear or Almost Clear (IGA 0–1) (L23.81)
- • Functional skin & dermatology impact requiring dermoscopy or punch in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: biopsy when atypical) evaluation (L23.81)
Allergic contact dermatitis due to animal (cat) (dog) dander Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | L23.81 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Dermatology: Acne, Eczema, Psoriasis & Rosacea | NLM Clinical Tables |
| Diagnostic / Lab Marker: Affected Body Surface in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: Area (BSA /) | Clear or Almost Clear (IGA 0–1) (L23.81) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Fasting Lipids & in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: ALT (if systemic) | Within baseline reference limits (L23.81) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D in Allergic contact dermatitis due to animal (cat) (dog) dander (L23.81: & hs-CRP) | 25(OH)D 40–65 ng/mL (L23.81) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Allergic contact dermatitis due to animal (cat) (dog) dander
Treatment selection for Allergic contact dermatitis due to animal (cat) (dog) dander depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Allergic contact dermatitis due to animal (cat) (dog) dander)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Gold-standard blind, compared against a dummy pill (placebo) Trial of the: What a 486-Participant Study Found Here, 0.15% AZE significantly improved the overall rTNSS compared with placebo over the 28-day study period. International archives of allergy and immunology • 2025-01-15 • Phase III Randomized Trial | N = 486 | 93/100 | PMID 39647474 ↗ |
| New Insights on Rapid Improvement in Skin Pain Severity and Its Impact on Quality of Life in: What a 440-Participant Study Found Patients with moderate-to-severe AD, treated with baricitinib, reported rapid improvements in skin pain severity by day 1 for baricitinib 2 mg and day 2 for baricitinib 1 mg and remained effective through 16 weeks of... Journal of cutaneous medicine and surgery • 2022-01-15 • Phase III Randomized Trial | N = 440 | 93/100 | PMID 35354410 ↗ |
| Can This Approach Help? Inside the Latest Research on Phase III study of Phlai capsules in the treatment of allergic rhinitis: A Phlai was safe. Asian Pacific journal of allergy and immunology • 2026-03-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 37302097 ↗ |
| Can This Approach Help? Inside the Latest Research on Safety and real-world benefits of a novel 0.5% epinastine skin-applied eyelid With its novel route of administration, 0.5% epinastine applied to the skin eyelid cream may be considered a unique, easy-to-use, once-daily treatment option to prevent the onset of seasonal allergic conjunctivitis. Japanese journal of ophthalmology • 2024-11-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 39259242 ↗ |
| Can This Approach Help? Inside the Latest Research on SQ House Dust Mite Sublingual Immunotherapy Tablet in Children With Allergic As a result of the coronavirus disease 2019 pandemic, asthma exacerbation rates were much lower than expected, contributing to the primary endpoint not being met. Allergy • 2025-12-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41064908 ↗ |
Allergic contact dermatitis due to animal (cat) (dog) dander Patient Community & “People Like Me” Threads
Filter Allergic contact dermatitis due to animal (cat) (dog) dander community threads and patient logs by age, biological sex, dosage, and treatment duration.